<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Department of ENT</title>
<link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/125</link>
<description/>
<pubDate>Sun, 06 Sep 2026 09:24:00 GMT</pubDate>
<dc:date>2026-09-06T09:24:00Z</dc:date>
<item>
<title>Study of bacterial flora in external auditory canal and middle ear in chronic otitis media, tubotympanic type patients</title>
<link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6395</link>
<description>Study of bacterial flora in external auditory canal and middle ear in chronic otitis media, tubotympanic type patients
Sai Sushma Gadi
BACKGROUND: &#13;
Chronic suppurative otitis media (CSOM) is typified by persistent inflammation &#13;
of the mastoid and middle ear mucosa, which results in ear drainage and TM &#13;
perforation1. &#13;
Geographical variation and patient demographic variables have been influencing &#13;
the antibiotic resistance pattern of CSOM. Both bacterial isolate resistance and the &#13;
excessive and illogical usage of broad spectrum antibiotics have grown widespread1. &#13;
Staphylococcus aureus (both methicillin-resistant [MRSA] and methicillin-sensitive &#13;
[MSSA]), Pseudomonas, Proteus, Coagulase-negative staphylococci, Enterococcus, and &#13;
Anaerobes are among the frequently isolated bacteria1. &#13;
AIMS AND OBJECTIVES: &#13;
1. To ascertain the aerobic bacterial isolates' microbial diversity in individuals &#13;
with tubotympanic-type chronic otitis media.  &#13;
2. To determine the antimicrobial susceptibility and resistance to antibiotics &#13;
thereby helping in earlier management of the disease. &#13;
METHODOLOGY: &#13;
SOURCE OF DATA &#13;
This prospective study is being undertaken in the Department of &#13;
Otorhinolaryngology at SHRI B M PATIL MEDICAL COLLEGE AND RESEARCH &#13;
CENTRE AND HOSPITAL [BLDE (DU) UNIVERSITY] ,Vijayapura from April &#13;
2023 to January 2025. &#13;
METHOD OF COLLECTION OF DATA &#13;
 Preoperative examination of the patient including complete clinical history. &#13;
 Characteristics of patients including age, gender, residence. &#13;
 The patient is thoroughly examined, with a focus on otoscopic findings to &#13;
XI &#13;
Docusign Envelope ID: 2920D593-692B-4D04-A21F-70EEE8B54013&#13;
assess the condition of the tympanic membrane and to examine the &#13;
oropharynx, nose, and throat. &#13;
 Patient will be subjected to investigations such as urine routine, blood routine &#13;
examinations and aerobic culture of the discharge from both the external &#13;
auditory canal and middle ear (under microscope). &#13;
 Sample from the external auditory canal is taken out with the help of Cotton &#13;
Swab. &#13;
 Then, external auditory canal is cleaned using alcohol and normal saline and &#13;
allowed to dry. &#13;
 Mucus extractor used to collect sample from middle ear. &#13;
 Both the samples are sent for aerobic culture and sensitivity. &#13;
RESULT: &#13;
Out of the 71 total swabs collected from external ear in our study, &#13;
Staphylococcus aureus showed 100% sensitivity to Gentamycin and Linezolid, 95.5% &#13;
to Clindamycin, 7.7% to Ciprofloxacin, and an overall sensitivity of 49.3% to the &#13;
antibiotics used in this hospital. Pseudomonas aeruginosa showed 66.7% Amikacin &#13;
and Colistin, 57.1% sensitivity to Meropenem, 50% to Cefepime, 38.5% to &#13;
Ciprofloxacin and an overall sensitivity of 25.4% to the antibiotics used in this &#13;
hospital. &#13;
Out of the total swabs collected from middle ear in our study, Staphylococcus &#13;
aureus showed 100% sensitivity to Linezolid and Clindamycin and an overall &#13;
sensitivity of 19.7% to the antibiotics used in this hospital. Pseudomonas aeruginosa &#13;
showed 100% Amikacin and Colistin, 86.2% to Ciprofloxacin, 52.6% to Meropenem, &#13;
50% to Cefepime and an overall sensitivity of 59.2% to the antibiotics used in this &#13;
hospital. &#13;
XII &#13;
Docusign Envelope ID: 2920D593-692B-4D04-A21F-70EEE8B54013&#13;
CONCLUSION: &#13;
Knowing the local susceptibility pattern of the causative agents is essential for &#13;
treating the infection effectively and for developing antibiotic policy, as the &#13;
susceptibility pattern of the pathogenic microorganisms is changing since antibiotics &#13;
are widely used and readily available.
</description>
<pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6395</guid>
<dc:date>2022-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Microdebrider- assisted turbinoplasty versus coblation Method of turbinoplasty - a comparative study</title>
<link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6394</link>
<description>Microdebrider- assisted turbinoplasty versus coblation Method of turbinoplasty - a comparative study
Reshma Rajeev
Introduction &#13;
Inferior turbinate hypertrophy is a major cause of chronic nasal obstruction, &#13;
significantly impairing nasal airflow and overall quality of life. Although medical &#13;
management with antihistamines, decongestants, and corticosteroids is the first line &#13;
of treatment, a subset of patients remains symptomatic and requires surgical &#13;
intervention. Various surgical techniques, including partial turbinectomy, &#13;
turbinoplasty, and submucosal tissue reduction, have been developed to improve &#13;
nasal patency while preserving mucosal function. Microdebrider-assisted &#13;
turbinoplasty (MAT) and coblation-assisted turbinoplasty (CAT) are two widely used &#13;
mucosa-sparing techniques. However, limited comparative studies exist evaluating &#13;
their efficacy, safety, and long-term outcomes. This study aims to compare the &#13;
clinical outcomes of MAT and CAT in the surgical management of inferior turbinate &#13;
hypertrophy. &#13;
Methods &#13;
This prospective comparative study included 60 patients diagnosed with symptomatic &#13;
inferior turbinate hypertrophy unresponsive to medical therapy. Patients were &#13;
randomly assigned to undergo either MAT (n = 30) or CAT (n = 30) under general &#13;
anesthesia. In the MAT group, a microdebrider was used for submucosal tissue &#13;
removal and turbinate lateralization, while in the CAT group, controlled &#13;
radiofrequency ablation was performed using a coblator wand before out-fracturing &#13;
the turbinate. Postoperative outcomes were assessed using the Nasal Obstruction &#13;
Symptom Evaluation (NOSE) score and objective airflow measurements at 1 month, &#13;
3 months, and 6 months postoperatively. Intraoperative bleeding, postoperative &#13;
healing, and complications were also evaluated. &#13;
 &#13;
 &#13;
Docusign Envelope ID: 165D166E-2E7B-4A05-AD83-C5843C3043D8&#13;
12 &#13;
 &#13;
 &#13;
 &#13;
 &#13;
 &#13;
 &#13;
Results &#13;
Both MAT and CAT showed significant improvements in NOSE scores, with mean &#13;
scores improving from 72.4 ± 8.6 preoperatively to 18.7 ± 4.2 at 6 months in the &#13;
MAT group, and from 73.1 ± 7.9 to 19.3 ± 5.1 in the CAT group (p &gt; 0.05). Peak &#13;
nasal inspiratory flow (PNIF) improved by 62.3% in the MAT group and 58.7% in &#13;
the CAT group at 6 months (p &gt; 0.05). Intraoperative blood loss was slightly lower in &#13;
the CAT group (21.5 ± 5.2 mL vs. 27.8 ± 6.4 mL in MAT, p &lt; 0.05). Postoperative &#13;
crusting and healing times were comparable between the two groups, with no &#13;
significant difference in complication rates or recurrence of turbinate hypertrophy. &#13;
Conclusion &#13;
MAT and CAT are both effective and safe surgical options for managing inferior &#13;
turbinate hypertrophy. While CAT offers a slight advantage in intraoperative &#13;
hemostasis, both techniques provide comparable symptom relief, nasal airflow &#13;
improvement, and mucosal preservation, making either a viable choice based on &#13;
surgeon preference and patient-specific factors.
</description>
<pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6394</guid>
<dc:date>2022-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>A study of sensorineural hearing loss in patients with diabetes mellitus by pure tone audiometry</title>
<link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6393</link>
<description>A study of sensorineural hearing loss in patients with diabetes mellitus by pure tone audiometry
Nivedha.N
BACKGROUND:  &#13;
Diabetes mellitus is a significant public health problem with many secondary &#13;
micro and macrovascular complications. [1]  The most underestimated complication of  &#13;
diabetes mellitus is sensorineural hearing loss.[1]  &#13;
In 1857, Jordao was the first to document the correlation between diabetes &#13;
mellitus and hearing impairment.  Incidence of hearing loss in diabetes patients ranges &#13;
up to 80%. The hearing loss observed in diabetic patients will be of progressive &#13;
bilateral sensorineural type affecting high frequencies.  [2] &#13;
Goal of the present study is to establish a relationship between glycemic &#13;
control and sensorineural hearing loss.  &#13;
OBJECTIVES OF THE STUDY:  &#13;
 To assess the association of sensorineural hearing loss in patients with &#13;
diabetes   mellitus.  &#13;
 To measure levels of HbA1c in diabetes mellitus patients to know the &#13;
glycemic control and its influence on sensorineural hearing loss .  &#13;
DESIGN OF STUDY: Hospital based cross-sectional study. &#13;
MATERIALS AND METHOD: &#13;
Study included 70 patients among which 35 were clinically diagnosed diabetes &#13;
mellitus patients experiencing hearing loss and 35 were non-diabetic patients with &#13;
similar complaints who were selected from the ENT and Medicine outpatient &#13;
departments at BLDE (Deemed to be University) Shri B.M.Patil Medical College and &#13;
Research Centre , Vijayapura. All participants were &lt; 60 years of age and were &#13;
chosen based on specific inclusion and exclusion criteria. Comprehensive history &#13;
XV &#13;
Docusign Envelope ID: 7881F31D-DA44-40F2-B6DF-BB9E17B7154E&#13;
taking, clinical examinations, and tuning fork tests were performed. Blood tests, &#13;
including fasting blood sugars (FBS), postprandial blood sugars (PPBS), and HbA1c &#13;
(glycosylated hemoglobin), performed on these patients. All the subjects underwent &#13;
pure tone audiometry, and the results were analyzed and documented. &#13;
RESULTS : &#13;
In our study SNHL is more prevalent in cases i.e reduced hearing with known &#13;
diabetic, whereas in non diabetic with reduced hearing controls only 20 % had SNHL &#13;
according to PTA values (right ear) .  &#13;
According to PTA values (left ear) , SNHL is more prevalent in cases i.e &#13;
reduced hearing with known diabetic, whereas in non diabetic with reduced hearing &#13;
controls only 22.9 % had SNHL .This signifies that SNHL is more prevalent in &#13;
diabetic patients compared to non -diabetic controls .  &#13;
Cases were further divided into two groups , HbA1C less than 7 were &#13;
considered as good control and HbA1C more than 7 were  considered as poor control . &#13;
In our study out of 35 cases only 11(31.43%) were good control patients and &#13;
the remaining 24(68.57%) were poor control patients. It was observed that all 11 good &#13;
controlled dm patients experienced mild SNHL whereas in poorly controlled dm &#13;
patients 3(40%) had severe SNHL and 16(66.7%) had moderate SNHL and 5 (14.3%) &#13;
had mild SNHL in right ear . &#13;
In the left ear out of 11 good controlled dm patients 7 (63.6%) experienced &#13;
mild SNHL and 4 (36.4%) had moderate SNHL ,whereas in poorly controlled dm &#13;
patients 3(8.6%) had very severe SNHL and 10 (28.6%) had severe SNHL and &#13;
14(40.0%) had moderate SNHL and 8 (22.9%) had mild SNHL in the left ear. pvalue &#13;
is less than 0.001 showing strong significance which proves poorly controlled &#13;
XVI &#13;
Docusign Envelope ID: 7881F31D-DA44-40F2-B6DF-BB9E17B7154E&#13;
diabetes mellitus patients exhibited more severe hearing loss compared to those with &#13;
well-controlled diabetes. &#13;
CONCLUSION: &#13;
The prevalence of sensorineural hearing loss (SNHL) is higher in patients with &#13;
type 2 diabetes based on PTA values, while patients with poorly controlled diabetes &#13;
mellitus, as indicated by HbA1c values, exhibited more severe hearing loss. In our &#13;
current study, we emphasize the importance of impact of diabetes on hearing health. &#13;
Therefore complete audiological evaluation and maintaining strict glycemic control is &#13;
crucial for reducing the impact of diabetes on hearing sensitivity.
</description>
<pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6393</guid>
<dc:date>2022-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Assessment of middle ear risk index factor on outcome of surgery for chronic otitis media</title>
<link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6392</link>
<description>Assessment of middle ear risk index factor on outcome of surgery for chronic otitis media
Adishree. Shivaji. Mali.
Background: &#13;
Chronic otitis media (COM) is described as a highly prevalent disease of the &#13;
middle ear which constitutes a serious health problem worldwide, especially in &#13;
developing countries. This study was done to evaluate the role of the middle ear risk &#13;
index (MERI) on the outcome of surgeries for COM in the form of successful graft &#13;
uptake and improvement in hearing. &#13;
Methods: &#13;
A total of 52 patients of COM were included in this study. Detailed ENT &#13;
examination and preoperative pure tone audiometry were done in all patients. MERI &#13;
score was calculated and patients were stratified based on the MERI score. All &#13;
patients were evaluated at the end of 3 months postoperatively, for the status of graft &#13;
uptake and improvement in hearing. &#13;
Results:  &#13;
The MERI was found to be a remarkable predictor of the outcome of surgeries &#13;
for COM. The patients with mild MERI scores had a significantly better prognosis &#13;
than patients with severe MERI scores. &#13;
Conclusions:  &#13;
MERI is a very useful and honest predictor of the graft uptake and hearing &#13;
benefit in patients undergoing surgeries for COM. It has an inverse relation with graft &#13;
uptake and hearing benefit. Based on the MERI score, the likelihood of surgical &#13;
success and hearing benefit could be explained to the patient of COM to give them &#13;
realistic expectations.
</description>
<pubDate>Sat, 01 Jan 2022 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6392</guid>
<dc:date>2022-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
